Showing results (81-90 of 120) with videos related to
Sort By:
Pageof 12
Therapeutic Advances in Medical Oncology|July 29, 2025
Pancreatic neuroendocrine tumors and MUTYH pathogenic variants: a multinational studyRachel P Riechelmann, Giovana T Torrezan, Emily Bergsland, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 11, 2016
Phase I study of pre-operative continuous 5-FU and sorafenib with external radiation therapy in locally advanced rectal adenocarcinomaRichard Kim, Gopi Kesaria Prithviraj, Ravi Shridhar, et al.British Journal of Cancer|April 8, 2021
A phase 1/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancerDae Won Kim, Elaine Tan, Jun-Min Zhou, et al.Scientific Reports|December 11, 2019
DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumorsMauro Cives, Stefano Partelli, Raffaele Palmirotta, et al.Pancreas|March 26, 2008
Multimodality management of a polyfunctional pancreatic endocrine carcinoma with markedly elevated serum vasoactive intestinal polypeptide and calcitonin levelsAejaz Nasir, Nancy M Gardner, Jonathan Strosberg, et al.Journal for Immunotherapy of Cancer|June 28, 2022
Development of anti-somatostatin receptors CAR T cells for treatment of neuroendocrine tumorsBarbara Mandriani, Eleonora Pellè, Francesco Mannavola, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2014
Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine TumorsTimothy J Hobday, Rui Qin, Diane Reidy-Lagunes, et al.European Journal of Cancer (Oxford, England : 1990)|May 8, 2022
A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancerRichard D Kim, Bence P Kovari, Maria Martinez, et al.Annals of Surgical Oncology|March 3, 2006
Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumorsDana A Osborne, Emmanuel E Zervos, Jonathan Strosberg, et al.Journal of Nuclear Medicine Technology|October 4, 2022
Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive ReviewEmran Askari, Soroush Zarehparvar Moghadam, Damian Wild, et al.Pageof 12